Hybenová D, Majtán V
Institute of Preventive and Clinical Medicine, Bratislava, Slovak Republic.
Pharmazie. 1997 Feb;52(2):157-9.
We have studied the postantibiotic effect (PAE) and postantibiotic sub-MICs effect (PA SME) of ciprofloxacin, pefloxacin, netilmicin and tobramycin on the production of phospholipase C (PLC) in a Pseudomonas aeruginosa strain isolated from clinical material. All antibiotics tested (postantibiotic phase evoked by 2.MIC) reduced the production of PLC, particularly pefloxacin to 13.2%. The PA phase evoked by 4.MIC of quinolones did not cause regrowth of P. aeruginosa and aminoglycosides inhibited PLC, in particular with tobramycin to 16.9%. The effect of PA SME (2.MIC) of netilmicin and tobramycin inhibited PLC more expressively (< 20%) than ciprofloxacin; pefloxacin did not allow regrowth. PA SMEs of the antibiotics tested reduced the production of PLC more effectively than PAE.
我们研究了环丙沙星、培氟沙星、奈替米星和妥布霉素对从临床材料中分离出的一株铜绿假单胞菌产生磷脂酶C(PLC)的抗生素后效应(PAE)和抗生素后亚抑菌浓度效应(PA SME)。所有测试的抗生素(2倍MIC引起的抗生素后阶段)均降低了PLC的产生,尤其是培氟沙星降至13.2%。喹诺酮类药物4倍MIC引起的PA阶段未导致铜绿假单胞菌再生长,氨基糖苷类药物抑制了PLC,特别是妥布霉素降至16.9%。奈替米星和妥布霉素的PA SME(2倍MIC)比环丙沙星更显著地抑制了PLC(<20%);培氟沙星不允许再生长。所测试抗生素的PA SMEs比PAE更有效地降低了PLC的产生。